Elsevier

The Lancet

Volume 347, Issue 9003, 16 March 1996, Pages 714-718
The Lancet

Article
Age at menopause as a risk factor for cardiovascular mortality

https://doi.org/10.1016/S0140-6736(96)90075-6Get rights and content

Abstract

Summary

Background Although an association of occurrence of menopause and subsequent oestrogen deficiency with increased cardiovascular disease has been postulated, studies on this association have not shown convincing results. We investigated whether age at menopause is associated with cardiovascular mortality risk.

Methods We studied a cohort of 12 115 postmenopausal women living in Utrecht, Netherlands, aged 50-65 years at enrolment in a breast cancer screening project. During follow-up of up to 20 years the women attended screening rounds at which we asked questions on menopausal status, age at menopause, medication use, cardiovascular risk factors, and ovarian function. Deaths were ascertained from the patient's family physicians. Life-table analysis and Cox regression analysis were used to investigate the association between age at menopause and cardiovascular mortality. All analyses were adjusted for biological age.

Findings 824 women died of cardiovascular causes. 1459 women had left the study area. The risk of cardiovascular mortality was higher for women with early menopauses than for those with late menopauses. The age-adjusted hazard ratio of age at menopause was 0·982 (95% Cl 0·968-0·996, p=0·01)—ie, for each year's delay in the menopause the cardiovascular mortality risk decreased by 2%. The extra risk of early menopause seemed to decrease with biological age (p for interaction 0·07); at biological age 60 the reduction of the annual hazard was 3%, but at age 80 there was no reduction. Adjustment for known cardiovascular risk factors and indicators of ovarian function did not significantly alter the risk estimate.

Interpretation These results support the hypothesis that longer exposure to endogenous oestrogens protects against cardiovascular diseases. The effect of an early menopause may be more important at younger biological ages.

References (28)

  • Jh Wuest et al.

    The degree of coronary atherosclerosis in bilaterally oophorectomised women

    Circulation

    (1953)
  • Au Rivin et al.

    The incidence and severity of cornary atherosclerosis in estrogen-treated males, and in females with a hypoestrogenic or a hyperestrogenic state

    Circulation

    (1954)
  • C. Bengtsson et al.

    Number of pregnancies, use of oral contraceptives and menopausal age in women with ischaemic heart disease, compared to a population sample of women

    Acta Med Scand

    (1973)
  • Cited by (551)

    • Occupational hazards and the onset of natural menopause

      2023, Maturitas
      Citation Excerpt :

      Menopause is a marker of the end of the reproductive life span and an accelerator of the aging process [3]. ANM is associated with shortened life expectancy [4], increased cardiovascular mortality [5,6], and risks of the age-related diseases mentioned above [7–9]. Since the nature of menopause is the exhaustion of ovarian function, prevention of accelerated ovarian senescence is a fundamental interest from the individual level and public health point of view.

    • Presence of diabetes mellitus affects vertigo outcome in vestibular migraine

      2022, American Journal of Otolaryngology - Head and Neck Medicine and Surgery
    View all citing articles on Scopus
    View full text